论文部分内容阅读
格列吡嗪控释片在2型糖尿病血糖控制和促进胰岛素分泌方面的有效性、安全性和剂量反应特性。2个多中心、随机、安慰剂对照的临床试验的结果。格列吡嗪胃肠治疗系统研究组。为研究格列吡嗪控释制剂通过胃肠治疗系统(GITS)对进餐后的2型糖尿病(T2DM)患者血糖、糖化血红蛋白(HbA1c
Validity, safety and dose-response characteristics of glipizide controlled release tablets in type 2 diabetes with glycemic control and insulin secretion promotion. Results of 2 multicenter, randomized, placebo-controlled clinical trials. Glipizide gastrointestinal treatment system research group. In order to study the effects of glipizide controlled-release (GITS) on the blood glucose, glycosylated hemoglobin (HbA1c) in post-prandial type 2 diabetes mellitus (T2DM)